Ā | Ā | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
Ā | Number of patients | Hazard ratio per 10 IDS units for p21 | 95% confidence interval | P | Hazard ratio per 10 IDS units for p21 | 95% confidence interval | P |
Overall survival | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāāp21 | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāāp21 nucleus | 64 | 0.96 | 0.77, 1.19 | 0.70 | 0.96 | 0.75, 1.22 | 0.73 |
āāāp21 cytoplasm | 63 | 1.12* | 1.01, 1.25 | 0.03* | 1.15* | 1.03, 1.28 | 0.01* |
āāāHER-2 (2+/3+ versus 0/1+) | 63 | 2.26* | 1.00, 5.27 | 0.05* | 3.14* | 1.15, 8.64 | 0.03* |
Relapse-free survival | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāāp21 | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāāp21 nucleus | 64 | 1.01 | 0.84, 1.22 | 0.89 | 1.03 | 0.84, 1.25 | 0.80 |
āāāp21 cytoplasm | 63 | 1.12* | 1.01, 1.24 | 0.03* | 1.15* | 1.02, 1.28 | 0.02* |
āāāHER-2 (2+/3+ versus 0/1+) | 63 | 2.60* | 1.19, 5.71 | 0.02* | 4.08* | 1.60, 10.39 | 0.003* |